Leading Innovator in the Field of Drug Discovery Optimization Recognized By Itanium Solutions Alliance For Novel Development on the Itanium 2 Processor.  

Beijing, CN – April 17, 2007 – The Itanium® Solutions Alliance (www.ItaniumSolutionsAlliance.org) announced today at the Intel Developer’s Forum that Gencom (www.GenomicComputation.com) was selected by a distinguished panel for Honorable Mention in the category of Humanitarian Impact.

The Humanitarian Impact category awards innovative use of applications running on Itanium® 2-based systems where these systems demonstrate a profound impact on humanity through research, social improvements or other humanitarian efforts.

The Itanium® Solutions Alliance is a global community of hardware, operating system and application vendors dedicated to accelerating the adoption and ongoing development of Itanium® 2-based solutions. Formed in September 2005, the Alliance is comprised of some of the most influential companies in the computing industry with a shared strategic commitment to deliver enterprise and technical computing solutions based on Intel® Itanium® 2 architecture.

The contest recognized top deployments of Itanium® 2-based systems in mission-critical computing environments in 3 categories; Humanitarian Impact, Enterprise Business Innovation, and Entrepreneurial Innovation.  The Humanitarian Impact Award recognized solutions that demonstrate a profound impact on humanity through research, social improvements or other humanitarian efforts.

Stony Brook University was awarded top honors for their ground-breaking biomedical research in the areas of HIV and AIDS research. Gencom was one of ten organizations from around the globe that received honorable mentions for their submission. See http://www.itaniumsolutionsalliance.org/programs/innovationcontest/finalist_humanitarian/  for a list of finalists in the Humanitarian Impact category.

Each of the winners demonstrated innovative computing using applications that take full advantage of Intel Itanium architecture.  Judges Matthew Eastwood, program vice president of IDC’s Enterprise Platform Group; William Jalby, head of Ph.D. graduate school covering economics, computer science and robotics at the University of Versailles; included Renee J. James, vice president and general manager of the Software and Solutions Group for Intel Corporation, Intel; Gale Persil, director of product management operations, Computer Associates; Chen Qiwang, Itanium product manager, PowerLeader Science & Technology Co., Ltd; and Mark K. Smith, managing director, Gelato Federation; selected the winning solutions based on  the difficulty of challenge, the results produced and originality.

Michael J. Colonna, Gencom’s Founder & Chief Technology Architect, said of the award “We are honored to be recognized and humbled to be considered alongside some of the most prestigious and innovative institutions in the world. We credit Intel for providing such an amazing technology which served as the foundation of our technical architecture”. Colonna also acknowledged the Itanium Solutions Alliance for providing a forum to highlight the advantages of the Itanium® 2. He added “The Alliance is a cadre of innovative institutions that stand unified in their commitment to advance the deployment of Itanium® 2-based solutions and we are very pleased to be a contributing member.”

About Gencom, Inc.

Gencom is leading innovation in the field of discovery optimization and is advancing the current state of high performance computing for clients engaged in functional genomics and other computationally intensive drug discovery activities. The company has set the performance standard for in-silico scientific discovery and innovation. Our goal is to dramatically improve people’s lives by providing researchers with the tools to identify the cause of disease and to develop innovative therapeutics.

Gencom’s revolutionary hyper-mesh computing architecture, based upon Intel’s Itanium® 2 processor and Microsoft technologies, significantly reduces drug discovery-to-market times for its clients. The Company is based in Irvine, CA with future locations being planned for Research Triangle Park, NC and Cold Spring Harbor, NY.

For additional information about Gencom, please visit www.GenomicComputation.com.